Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02112825 · ClinicalTrials.gov registry record · NA
Exercise as an Adjunct Therapy to Reduce Blood Pressure in Chronic Kidney Disease
A NA study of Focus Chronic Kidney Disease With Hypertension, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT02112825 is a NA study of Focus Chronic Kidney Disease With Hypertension that has completed, run by University of Minnesota. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02112825, a NA study of Focus Chronic Kidney Disease With Hypertension, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The general objective of the study is to investigate the effect of regular aerobic exercise on resting and 24-hr blood pressure levels in men and women with stage 3-4 kidney disease and hypertension.
Conditions Studied
Interventions
- BEHAVIORAL Exercise
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2013-07 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02112825
The ClinicalTrials.gov registry entry for NCT02112825 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Focus Chronic Kidney Disease With Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Exercise is the first listed.
NCT02112825 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT02112825 about?
NCT02112825 is a clinical study titled "Exercise as an Adjunct Therapy to Reduce Blood Pressure in Chronic Kidney Disease". The general objective of the study is to investigate the effect of regular aerobic exercise on resting and 24-hr blood pressure levels in men and women with stage 3-4 kidney disease and hypertension.
What is the current status of trial NCT02112825?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2013-07. Estimated completion is 2015-06.
What conditions does trial NCT02112825 study?
This clinical trial studies the following conditions: Focus Chronic Kidney Disease With Hypertension.
What interventions are being tested in trial NCT02112825?
The interventions under investigation include: Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT02112825?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02112825 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.